RESUMO Introdução: A sarcopenia está associada a um risco aumentado de quedas em diversas populações. Pacientes com doença renal crônica (DRC) em hemodiálise (HD) apresentam maior prevalência de fraqueza e atrofia muscular. O objetivo deste estudo foi investigar a associação entre parâmetros de sarcopenia e histórico de quedas nessa população. Métodos: Um estudo transversal foi realizado para avaliar 111 participantes com DRC em HD (54 ± 15,6 anos; 59,5% homens). A sarcopenia foi definida por baixa força muscular (dinamometria manual) e baixa massa muscular (impedância bioelétrica). O histórico de quedas foi autorreferido. Análises bivariadas foram realizadas, e um modelo de regressão logística multivariada foi utilizado para avaliar a associação entre sarcopenia e quedas, ajustado por fatores de confusão. Resultados: Na análise multivariada, a sarcopenia não foi independentemente associada ao histórico de quedas (OR = 1,73; p = 0,40). No entanto, a idade avançada (OR = 1,04 por ano; p = 0,03) e o histórico de AVC (OR = 6,07; p = 0,05) foram identificados como preditores independentes e significativos de quedas. Conclusão: O histórico de quedas não esteve independentemente associado à força ou à massa muscular em pacientes com DRC em HD. Estudos longitudinais futuros são necessários para investigar outros fatores associados a esse desfecho.
Introduction: Sarcopenia has been associated with an increased risk of falls in diverse populations. Patients with end-stage renal disease (ESRD) undergoing hemodialysis (HD) have an increased prevalence of muscle weakness and wasting. The aim of this study was to investigate the association between parameters of sarcopenia and a history of falls in ESRD patients on HD. Methods: A cross-sectional study was utilized to assess 111 participants with ESRD on HD (54 ± 15.6 years; 59.5% men). Sarcopenia was defined by low muscle strength (handgrip dynamometry) and low muscle mass (bioelectrical impedance). History of falls was self-reported. Bivariate analyses were performed, and a multivariate logistic regression model was used to assess the association between sarcopenia and falls while adjusting for confounders. Results: In the multivariate analysis, sarcopenia was not independently associated with a history of falls (OR = 1.73; p = 0.40). However, advanced age (OR = 1.04 per year; p = 0.03) and a history of stroke (OR = 6.07; p = 0.05) were identified as significant independent predictors of falls. Conclusion: History of falls was not independently associated with muscle strength or mass in ESRD patients on HD. Future longitudinal studies are needed to investigate other factors associated with this outcome.
Introduction: Sarcopenia has been associated with an increased risk of falls in diverse populations. Patients with end-stage kidney disease (ESRD) undergoing hemodialysis (HD) have an increased prevalence of muscle weakness and wasting. The aim of this study was to investigate the association between parameters of sarcopenia and a history of falls in ESRD patients in HD. Methods: A cross-sectional study design was utilized to assess 111 participants with ESRD in HD (54 ± 15.6 years; 59.5% men) in a tertiary hospital in Maringa-PR. Sarcopenia status was determined through the measure of muscle strength and mass. Muscle strength was assessed through hand grip strength utilizing a handheld dynamometer. Muscle mass was estimated through bioelectrical impedance. Falls’ history was assessed with the fifth question of the SARC-F questionnaire. Data normality was assessed with the Shapiro-Wilk test. The association of the sarcopenia parameters with a falls history was analyzed with the chi-square test and Cramér’s V to measure effect size. Results: No association was found among the parameters of sarcopenia or its diagnosis and a history of falls in this population ( p > 0.05). Participants who reported falling in the previous year were older (60 ± 16.7 vs. 51 ± 14.7 years, p = 0.01) and had a history of cerebrovascular disease (14.3% vs. 2.4%, p = 0.02). Conclusion: Falls history was not associated with muscle strength or mass in ESRD patients in HD. Future longitudinal studies are needed to investigate other factors associated with this outcome.